| Publications | PubMed=8027550; DOI=10.4049/jimmunol.153.3.1225
Francesco M. Marincola, Peter Shamamian, Richard B. Alexander, James R. Gnarra, Regina L. Turetskaya, Sergei Arturovich Nedospasov, Toni B. Simonis, Jeffery Karl Taubenberger, John R. Yannelli, Arnold Mixon, Nicholas P. Restifo ...Show all 13 authors... , Meenhard Herlyn, Steven A. Rosenberg; Show fewer authors
Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
J. Immunol. 153:1225-1237(1994) PubMed=8081556; DOI=10.1097/00002371-199407000-00002; PMCID=PMC2561308
Francesco M. Marincola, Peter Shamamian, Toni B. Simonis, Andrea D. Abati, Julia A. Hackett, Teresita O'Dea, Patricia A. Fetsch, John R. Yannelli, Nicholas P. Restifo, James J. Mule, Steven A. Rosenberg;
Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines.
J. Immunother. Emphasis Tumor Immunol. 16:13-23(1994) PubMed=8537970; DOI=10.1093/jnci/88.2.100; PMCID=PMC2248456
Nicholas P. Restifo, Francesco M. Marincola, Yutaka Kawakami, Jeffery Karl Taubenberger, John R. Yannelli, Steven A. Rosenberg;
Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
J. Natl. Cancer Inst. 88:100-108(1996) PubMed=9598804; DOI=10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N
Graeme J. Walker, Jose F. Flores, J. Michael Glendening, Amy Hsiu-Ti Lin, Isabel D.C. Markl, Jane W. Fountain;
Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.
Genes Chromosomes Cancer 22:157-163(1998) PubMed=9670966; DOI=10.4049/jimmunol.161.2.877
Maria P. Bettinotti, Christina J. Kim, Kang-Hun Lee, Matthew Roden, Janice N. Cormier, Monica C. Panelli, Kenneth K. Parker, Francesco M. Marincola;
Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy.
J. Immunol. 161:877-889(1998) PubMed=10048982; DOI=10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A; PMCID=PMC2072935
Janice N. Cormier, Monica C. Panelli, Julia A. Hackett, Maria P. Bettinotti, Arnold Mixon, John R. Wunderlich, Linda L. Parker, Nicholas P. Restifo, Soldano Ferrone, Francesco M. Marincola;
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.
Int. J. Cancer 80:781-790(1999) PubMed=10754339; DOI=10.4049/jimmunol.164.8.4382
Monica C. Panelli, Maria P. Bettinotti, Kate Lally, Galen Anthony Ohnmacht, Yong Li, Paul F. Robbins, Adam Riker, Steven A. Rosenberg, Francesco M. Marincola;
A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12.
J. Immunol. 164:4382-4392(2000) PubMed=15467732; DOI=10.1038/sj.onc.1208152
Hideaki Tanami, Issei Imoto, Akira Hirasawa, Yasuhiro Yuki, Itaru Sonoda, Jun Inoue, Kohichiroh Yasui, Akiko Misawa-Furihata, Yutaka Kawakami, Johji Inazawa;
Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Oncogene 23:8796-8804(2004) PubMed=16470173; DOI=10.1038/sj.jid.5700193
Ena Wang, Sonia Voiculescu, Isabelle Caroline Le Poole, Mona El-Gamil, Xin Li, Marianna Sabatino, Paul F. Robbins, Brian J. Nickoloff, Francesco M. Marincola;
Clonal persistence and evolution during a decade of recurrent melanoma.
J. Invest. Dermatol. 126:1372-1377(2006) PubMed=18172304; DOI=10.1158/0008-5472.CAN-07-1939
Marianna Sabatino, Ying-Dong Zhao, Sonia Voiculescu, Alessandro Monaco, Paul F. Robbins, Laszlo Karai, Brian J. Nickoloff, Michele Maio, Silvia Selleri, Francesco M. Marincola, Ena Wang;
Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
Cancer Res. 68:122-131(2008) PubMed=25502142; DOI=10.1038/ncomms6712; PMCID=PMC4428333
Judith Muller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiang-Ju Kong, Patricia Abrao Possik, Paulien D.M. Cornelissen-Steijger, Marnix H. Geukes Foppen, Kristel Kemper ...Show all 19 authors... , Colin Ronald Goding, Ultan McDermott, Christian Blank, John B.A.G. Haanen, Thomas G. Graeber, Antoni Ribas, Roger S. Lo, Daniel S. Peeper; Show fewer authors
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Nat. Commun. 5:5712.1-5712.15(2014) PubMed=25538140; DOI=10.15252/msb.20145450; PMCID=PMC4300494
Marjon A. Smit, Gianluca Maddalo, Kylie Greig, Linsey M. Raaijmakers, Patricia Abrao Possik, Bas van Breukelen, Salvatore Cappadona, Albert J.R. Heck, A.F. Maarten Altelaar, Daniel S. Peeper;
ROCK1 is a potential combinatorial drug target for BRAF mutant melanoma.
Mol. Syst. Biol. 10:772-772(2014) PubMed=25485619; DOI=10.1038/nbt.3080
Christiaan Klijn, Steffen Durinck, Eric W. Stawiski, Peter M. Haverty, Zhao-Shi Jiang, Han-Bin Liu, Jeremiah Degenhardt, Oleg Mayba, Florian Gnad, Jin-Feng Liu, Gregoire Pau ...Show all 30 authors... , Jens Reeder, Yi Cao, Kiran Mukhyala, Suresh K. Selvaraj, Ma-Mie Yu, Gregory J. Zynda, Matthew J. Brauer, Thomas D. Wu, Robert Clifford Gentleman, Gerard Manning, Robert L. Yauch, Richard Bourgon, David Stokoe, Zora Modrusan, Richard M. Neve, Frederic J. de Sauvage, Jeffrey Settleman, Somasekar Seshagiri, Ze-Min Zhang; Show fewer authors
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015) |
|---|
